Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/GNT1112352]Researchers: A/Pr Jason Grebely (Principal investigator)
Brief description In Australia, hepatitis C is associated with considerable morbidity and mortality, costing $9.2 billion to the health care system. In the next year, side-effect prone hepatitis C therapies will be replaced with simple, tolerable, interferon-free therapies (cure >90%) that can reverse liver disease progression. My goal is to further develop my established research program in population-health related to HCV epidemiology, and therapeutic strategies, with a specific focus on PWID.
Funding Amount $463,652.00
Funding Scheme Career Development Fellowships
Notes Population Health CDF
- nhmrc : GNT1112352
- PURL : https://purl.org/au-research/grants/nhmrc/GNT1112352